News

June 2017

Thanks to our collaboration with Vall d’Hebron Institute of Research (VHIR), a dproof of concept of SEFALDIN efficacy in melanoma have been done. 

 

 See more: A study of Vall d’Hebron opens a new therapeutic strategy for melanoma treatment